BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Szabo TM, Frigy A, Nagy EE. Targeting Mediators of Inflammation in Heart Failure: A Short Synthesis of Experimental and Clinical Results. Int J Mol Sci 2021;22:13053. [PMID: 34884857 DOI: 10.3390/ijms222313053] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Paraskevaidis I, Farmakis D, Papingiotis G, Tsougos E. Inflammation and Heart Failure: Searching for the Enemy-Reaching the Entelechy. J Cardiovasc Dev Dis 2023;10. [PMID: 36661914 DOI: 10.3390/jcdd10010019] [Reference Citation Analysis]
2 Treille de Grandsaigne H, Bouisset F, Porterie J, Biendel C, Marcheix B, Lairez O, Labaste F, Elbaz M, Galinier M, Delmas C. Incidence, management, and prognosis of post-ischaemic ventricular septal defect: Insights from a 12-year tertiary centre experience. Front Cardiovasc Med 2022;9:1066308. [PMID: 36561773 DOI: 10.3389/fcvm.2022.1066308] [Reference Citation Analysis]
3 Szczepanska-Sadowska E. The Heart as a Target of Vasopressin and Other Cardiovascular Peptides in Health and Cardiovascular Diseases. Int J Mol Sci 2022;23. [PMID: 36430892 DOI: 10.3390/ijms232214414] [Reference Citation Analysis]
4 Kotlyarov S. Genetic and Epigenetic Regulation of Lipoxygenase Pathways and Reverse Cholesterol Transport in Atherogenesis. Genes 2022;13:1474. [DOI: 10.3390/genes13081474] [Reference Citation Analysis]